Literature DB >> 26956402

An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.

A Hernández-Martín1, A Duat-Rodríguez2.   

Abstract

Neurofibromatosis type 1 (NF1) is the most common neurocutaneous syndrome and probably the one best known to dermatologists. Although the genetic locus of NF1 was identified on chromosome 17 in 1987, diagnosis of the disease is still based primarily on clinical observations. The 7 diagnostic criteria of the National Institutes of Health, which were established in 1988, include 3 skin manifestations (café-au-lait spots, freckling on flexural areas, and cutaneous neurofibromas). The age at which these diagnostic lesions appear is variable: onset can be late in some patients while others never develop certain symptoms. Definitive diagnosis may therefore be delayed by years. Although the appearance of the characteristic café-au-lait spots and freckling in the early years of childhood are very suggestive of the disease, these signs are not pathognomonic and, in isolation, do not constitute sufficient evidence to establish a definitive diagnosis. Thus, other diagnoses should be considered in patients whose only symptoms are café-au-lait spots and freckling. By contrast, the presence of multiple cutaneous neurofibromas or at least 1 plexiform neurofibroma is a very specific indication of NF1. Identification of the different types of neurofibroma allows us to confirm the diagnosis and initiate appropriate management.
Copyright © 2016 AEDV. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Consejo genético; Genetic counseling; Glioma; Glomus tumor; Juvenile xanthogranuloma; Malignant peripheral nerve sheath tumor; Melanoma; Neurofibromatosis tipo 1; Neurofibromatosis type 1; Nevus anemicus; Tumor glómico; Tumor maligno de vaina nerviosa de nervio periférico; Xantogranuloma juvenil

Mesh:

Year:  2016        PMID: 26956402     DOI: 10.1016/j.ad.2016.01.009

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  6 in total

Review 1.  Familial Cancers of Head and Neck Region.

Authors:  Reshma Venugopal; Radhika Manoj Bavle; Paremala Konda; Sudhakara Muniswamappa; Soumya Makarla
Journal:  J Clin Diagn Res       Date:  2017-06-01

2.  Decayed, missing, and restored teeth in patients with Neurofibromatosis Type 1.

Authors:  Reinhard E Friedrich; Anika Reul
Journal:  J Clin Exp Dent       Date:  2018-02-01

3.  NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.

Authors:  Jean-Philippe Brosseau; Chung-Ping Liao; Yong Wang; Vijay Ramani; Travis Vandergriff; Michelle Lee; Amisha Patel; Kiyoshi Ariizumi; Lu Q Le
Journal:  Nat Commun       Date:  2018-11-27       Impact factor: 14.919

4.  Hypomelanotic melanoma detected by the "little red riding hood sign" in a patient with neurofibromatosis type 1.

Authors:  Roberta Giuffrida; Maximilian Uranitsch; Karin Schmid; Teresa Deinlein; Fabrizio Favero; Iris Zalaudek
Journal:  Dermatol Pract Concept       Date:  2017-07-15

Review 5.  New Model Systems and the Development of Targeted Therapies for the Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.

Authors:  Kyle B Williams; David A Largaespada
Journal:  Genes (Basel)       Date:  2020-04-28       Impact factor: 4.141

6.  Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.

Authors:  Marie-Laure Armand; Charles Taieb; Aline Bourgeois; Mireille Bourlier; Mohammed Bennani; Christine Bodemer; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2019-05-03       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.